Metastases detected at the time of diagnosis of primary pediatric extremity osteosarcoma at diagnosis: imaging features.
about
Review of Osteosarcoma and Current ManagementAnti-osteosarcoma effects and mechanisms of 4-O-amino-phenol-4'-demethylepipodophyllotoxin ether.Pediatric Osteosarcoma: An Updated ReviewTherapeutic Implications of PPARgamma in Human Osteosarcoma.Osteosarcoma Overview.Lysophosphatidic acid acyltransferase β (LPAATβ) promotes the tumor growth of human osteosarcoma.Clinical characteristics and prognosis of osteosarcoma in young children: a retrospective series of 15 cases.Childhood and adolescent cancer statistics, 2014.Defective osteogenic differentiation in the development of osteosarcoma.BET inhibitors induce apoptosis through a MYC independent mechanism and synergise with CDK inhibitors to kill osteosarcoma cellsSerum tumor markers in pediatric osteosarcoma: a summary review.Osteosarcoma of jawsPre-treatment serum lactate dehydrogenase and alkaline phosphatase as predictors of metastases in extremity osteosarcomaThe Current and Future Therapies for Human Osteosarcoma.MiR-193a-3p and miR-193a-5p suppress the metastasis of human osteosarcoma cells by down-regulating Rab27B and SRR, respectively.Changes in cell shape are correlated with metastatic potential in murine and human osteosarcomas.Should contralateral exploratory thoracotomy be advocated for children with osteosarcoma and early unilateral pulmonary metastases?Risk factors for metastatic disease at presentation with osteosarcoma: an analysis of the SEER database.IGFBP5 domains exert distinct inhibitory effects on the tumorigenicity and metastasis of human osteosarcoma.Modulation of u-PA, MMPs and their inhibitors by a novel nutrient mixture in pediatric human sarcoma cell lines.Diagnostic accuracy of CD44V6 for osteosarcoma: a meta-analysis.In vitro modulation of MMP-2 and MMP-9 in pediatric human sarcoma cell lines by cytokines, inducers and inhibitors.STAT3 inhibitor, cucurbitacin I, is a novel therapeutic agent for osteosarcoma.Expression of c-FLIP in pulmonary metastases in osteosarcoma patients and human xenografts.Molecular basis of differentiation therapy for soft tissue sarcomas.Uev1A facilitates osteosarcoma differentiation by promoting Smurf1-mediated Smad1 ubiquitination and degradation.Does rarity mean imparity? Biological characteristics of osteosarcoma cells originating from the spine.Establishment and Characterization of a Human Small Cell Osteosarcoma Cancer Stem Cell Line: A New Possible In Vitro Model for Discovering Small Cell Osteosarcoma Biology.Osteosarcoma with metastasis at initial diagnosis: Current outcomes and prognostic factors in the context of a comprehensive cancer center.Osteogenic Sarcoma: Systemic Chemotherapy Options for Localized Disease.Insulin-like growth factor binding protein 5 suppresses tumor growth and metastasis of human osteosarcoma.S100A6 expression and function in human osteosarcoma.MALAT1 predicts poor survival in osteosarcoma patients and promotes cell metastasis through associating with EZH2.Tumor Suppressor WWOX inhibits osteosarcoma metastasis by modulating RUNX2 function.Targeting LncRNA-MALAT1 suppresses the progression of osteosarcoma by altering the expression and localization of β-catenin.Current and future therapeutic approaches for osteosarcoma.Energy stress-induced lncRNA HAND2-AS1 represses HIF1α-mediated energy metabolism and inhibits osteosarcoma progression.Chromatin remodeling protein HELLS is upregulated by inactivation of the RB-E2F pathway and is nonessential for osteosarcoma tumorigenesis
P2860
Q28077590-DDDD2353-DB32-4761-ABA6-68F243161E48Q33317664-23248200-3141-4B67-9FBF-5558FCAAA21DQ33583291-4EDEDD54-80EC-48AA-831D-22E89BC3FBD4Q33674615-4572D347-2B5A-4346-8F9E-58857DDEEEEFQ33725511-984776DC-4D0F-4B66-AA8B-AA09789E8F93Q33769959-02E1EE89-1F04-443E-A42B-3D6F011AB344Q34028842-92C24C95-A98E-41BF-9D8A-2AB041774636Q34401667-24E8BCFE-E72C-431E-855F-391FE110D9D8Q34700590-2DD6A409-3212-44D3-8362-9870AB73DF37Q35574955-2C68FEA6-C82A-4B0E-8A3E-5D55FDF05BBEQ35984687-BD4878B8-7F3D-4873-A64F-3AC89768F33AQ36181176-EDB4C070-1EB7-4E56-A63A-BB43306CA541Q36290012-24097F8B-E212-41F0-98BB-A0708AA56955Q36514299-530219EB-FA4B-4CAC-AAC2-75C215C29F07Q36706415-9C5E5D49-0214-4243-94A3-4BF8518C591BQ36736913-A06D33A1-8BC9-4355-9288-803C04C0D0E1Q36822729-8D9F6512-F8B6-4F61-B1B2-4BF11B8E93B8Q36946002-CF3E40D9-A7E1-4D5E-8F53-6F7C5AA2D252Q36992847-A1731EA7-F895-4EE7-8940-525F3E0C8CA3Q37313387-4C260024-A52D-4B9F-9031-C13508A357DCQ37390884-D3288659-B995-425C-8FCF-C12C1CBE2624Q37401952-E801D334-BE1F-4C5D-822A-2A8F1F41DC47Q37427029-4865F118-9B89-4EC8-9F76-143CAAD1BA06Q37443887-9E66B24B-205D-4B21-A744-B4A991EADC94Q38588243-51A3DF8E-BBC5-4D7F-B84C-82FABA9D3FFFQ38647634-E5F8C469-9D4D-4319-8DD1-AB4A0A4D0FE4Q38702037-AB2C428D-362A-4C5D-BAB5-B714717B6C18Q38744582-60529195-E476-4B85-8734-C9B1CDBCE824Q39155292-E99E45A8-AB79-4A90-BE59-25AEE28AB97FQ39229404-20698770-F34D-4F31-9BA9-20070AF480A8Q39565320-8FA10243-0731-48CE-84E6-9286976C0346Q39963499-84620CD2-7C98-4E20-B767-C915D9544D4DQ41470862-3AF75577-7213-429B-8D6F-9417608275FAQ41991686-FF5C81DD-1D3A-47DF-85D6-90819542754FQ47162683-FDDAFF8C-BFD9-47FB-AE76-EA92B13388E1Q47360357-F15EED5A-C776-49CC-B3AB-6585B8A40BA7Q55026439-E591EA59-053F-405A-8954-405F31F263F0Q57753288-A5BCC367-76E3-4902-9B17-8E8922285D0B
P2860
Metastases detected at the time of diagnosis of primary pediatric extremity osteosarcoma at diagnosis: imaging features.
description
1999 nî lūn-bûn
@nan
1999 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Metastases detected at the tim ...... t diagnosis: imaging features.
@ast
Metastases detected at the tim ...... t diagnosis: imaging features.
@en
type
label
Metastases detected at the tim ...... t diagnosis: imaging features.
@ast
Metastases detected at the tim ...... t diagnosis: imaging features.
@en
prefLabel
Metastases detected at the tim ...... t diagnosis: imaging features.
@ast
Metastases detected at the tim ...... t diagnosis: imaging features.
@en
P2093
P2860
P1433
P1476
Metastases detected at the tim ...... t diagnosis: imaging features.
@en
P2093
P2860
P304
P356
10.1002/(SICI)1097-0142(19991015)86:8<1602::AID-CNCR31>3.0.CO;2-R
P407
P577
1999-10-01T00:00:00Z